OVERVIEW

Review and Interpretation of the 2019 ASCO Meeting Videos is organzed by Indiana University School of Medicine (IUSM).

Accreditation:
Nurses
Indiana University School of Medicine designates this activity for a maximum of 5.75 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists
Indiana University School of Medicine designates this activity for 5.75 ACPE contact hours. Pharmacists should only claim credit commensurate with the extent of their participation in the activity. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

Physicians
Indiana University School of Medicine designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Overview:
Designed for hematologists, medical oncologists, oncology nurses, oncology pharmacists and radiation oncologists, this program will provide the participants with the latest information available as presented at the 2019 American Society of Clinical Oncology (ASCO) Meeting, a highly valued conference that focuses on the latest research findings in the treatment of cancer. Oncology/Hematology faculty members from the Indiana University School of Medicine and other academic centers will provide participants with analysis of the more clinically applicable presentations at this year’s ASCO meeting.

Objectives:
At the end of this activity, participants should be able to:
• Recall and describe the newest developments in the treatment of hematological cancers, breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, melanoma, head/neck cancer, and precision medicine
• Integrate multimodality treatment strategies, including radiation therapy, chemotherapy, immunotherapy, and targeted therapy, into the management of patients with cancer
• Based on the most up-to-date treatments described in learning sessions, apply new knowledge about therapies of solid tumors and hematologic malignancies into their clinical practice
• Integrate the most up-to-date information on genomic analyses of cancer into their clinical practice